Marc R Schneebaum - Net Worth and Insider Trading
Marc R Schneebaum Net Worth
The estimated net worth of Marc R Schneebaum is at least $10 Million dollars as of 2024-09-21. Marc R Schneebaum is the CFO of Madrigal Pharmaceuticals Inc and owns about 41,668 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $10 Million. Marc R Schneebaum is also the Director of Genvec Inc and owns about 50 shares of Genvec Inc (GNVC) stock worth over $360. Details can be seen in Marc R Schneebaum's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc R Schneebaum has not made any transactions after 2018-06-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marc R Schneebaum
Marc R Schneebaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marc R Schneebaum owns 2 companies in total, including Madrigal Pharmaceuticals Inc (MDGL) , and Genvec Inc (GNVC) .
Click here to see the complete history of Marc R Schneebaum’s form 4 insider trades.
Insider Ownership Summary of Marc R Schneebaum
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals Inc | 2019-03-07 | Chief Financial Officer |
| GNVC | Genvec Inc | 2017-06-16 | director |
Marc R Schneebaum Latest Holdings Summary
Marc R Schneebaum currently owns a total of 2 stocks. Among these stocks, Marc R Schneebaum owns 41,668 shares of Madrigal Pharmaceuticals Inc (MDGL) as of June 11, 2018, with a value of $10 Million and a weighting of 100%. Marc R Schneebaum also owns 50 shares of Genvec Inc (GNVC) as of April 9, 2008, with a value of $360 and a weighting of 0%.
Latest Holdings of Marc R Schneebaum
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MDGL | Madrigal Pharmaceuticals Inc | 2018-06-11 | 41,668 | 233.44 | 9,727,020 |
| GNVC | Genvec Inc | 2008-04-09 | 50 | 7.19 | 360 |
Holding Weightings of Marc R Schneebaum
Marc R Schneebaum Form 4 Trading Tracker
According to the SEC Form 4 filings, Marc R Schneebaum has made a total of 0 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 10,099 shares on June 11, 2018, which brought Marc R Schneebaum around $3 Million.
According to the SEC Form 4 filings, Marc R Schneebaum has made a total of 0 transactions in Genvec Inc (GNVC) over the past 5 years. The most-recent trade in Genvec Inc is the acquisition of 50 shares on April 9, 2008, which cost Marc R Schneebaum around $9,900.
Insider Trading History of Marc R Schneebaum
- 1
Marc R Schneebaum Trading Performance
GuruFocus tracks the stock performance after each of Marc R Schneebaum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marc R Schneebaum is -32.69%. GuruFocus also compares Marc R Schneebaum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marc R Schneebaum within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Marc R Schneebaum's insider trading performs compared to the benchmark.
Performance of Marc R Schneebaum
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.65 | | | | | |
| Relative Return to S&P 500(%) | -11.14 | | | | | |
Marc R Schneebaum Ownership Network
Marc R Schneebaum Owned Company Details
What does Madrigal Pharmaceuticals Inc do?
Who are the key executives at Madrigal Pharmaceuticals Inc?
Marc R Schneebaum is the Chief Financial Officer of Madrigal Pharmaceuticals Inc. Other key executives at Madrigal Pharmaceuticals Inc include director & President and CEO William John Sibold , Senior VP & Chief Pharma Dev. Robert E. Waltermire , and director & 10 percent owner Fred B Craves .
Madrigal Pharmaceuticals Inc (MDGL) Insider Trades Summary
Over the past 18 months, Marc R Schneebaum made no insider transaction in Madrigal Pharmaceuticals Inc (MDGL). Other recent insider transactions involving Madrigal Pharmaceuticals Inc (MDGL) include a net purchase of 424,685 shares made by Baker Bros. Advisors Lp , a net sale of 12,736 shares made by Robert E. Waltermire , and a net sale of 100,000 shares made by Paul A Friedman .
In summary, during the past 3 months, insiders sold 6,363 shares of Madrigal Pharmaceuticals Inc (MDGL) in total and bought 0 shares, with a net sale of 6,363 shares. During the past 18 months, 303,930 shares of Madrigal Pharmaceuticals Inc (MDGL) were sold and 424,685 shares were bought by its insiders, resulting in a net purchase of 120,755 shares.
Madrigal Pharmaceuticals Inc (MDGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Madrigal Pharmaceuticals Inc Insider Transactions
Marc R Schneebaum Mailing Address
Above is the net worth, insider trading, and ownership report for Marc R Schneebaum. You might contact Marc R Schneebaum via mailing address: Genvec, Inc., 65 West Watkins Mill Road, Gaithersburg Md 20878.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
